The Food and Drug Administration(FDA) approved avapritinib for adult patients with advanced systemic mastocytosis, including patients with aggressive systemic mastocytosis...
The Food and Drug Administration(FDA) approved avapritinib for adult patients with advanced systemic mastocytosis, including patients with aggressive systemic mastocytosis...